Literature DB >> 20075077

Foxp3 expression in p53-dependent DNA damage responses.

Da-Jung Jung1, Dong-Hoon Jin, Seung-Woo Hong, Jee-Eun Kim, Jae-Sik Shin, Daejin Kim, Byung-Joo Cho, Young-Il Hwang, Jae-Seung Kang, Wang-Jae Lee.   

Abstract

The forkhead transcription factor, Foxp3, is thought to act as a master regulator that controls (suppresses) expression of the breast cancer oncogenes, SKP2 and HER-2/ErbB2. However, the mechanisms that regulate Foxp3 expression and thereby modulate tumor development remain largely unexplored. Here, we demonstrate that Foxp3 up-regulation requires p53 function, showing that Foxp3 expression is directly regulated by p53 upon DNA damage responses in human breast and colon carcinoma cells. Treatment with the genotoxic agents, doxorubicin or etoposide, induced Foxp3 expression in p53-positive carcinoma cells, but not in cells lacking p53 function. Furthermore, knock down of endogenous wild-type p53 using RNA interference abrogated Foxp3 induction by genotoxic agents, and exogenous expression of p53 in cells lacking p53 restored the responsiveness of Foxp3 to DNA-damaging stresses. In addition, Foxp3 knock down blunted the p53-mediated growth inhibitory response to DNA-damaging agents. These results suggest that induction of Foxp3 in the context of tumor suppression is regulated in a p53-dependent manner and implicate Foxp3 as a key determinant of cell fate in p53-dependent DNA damage responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20075077      PMCID: PMC2832950          DOI: 10.1074/jbc.M109.047985

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Prognostic impact of Skp2 and p27 in human breast cancer.

Authors:  Frank Traub; Michael Mengel; Hans J Lück; Hans H Kreipe; Reinhard von Wasielewski
Journal:  Breast Cancer Res Treat       Date:  2006-04-25       Impact factor: 4.872

Review 2.  The p53 pathway: positive and negative feedback loops.

Authors:  Sandra L Harris; Arnold J Levine
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

Review 3.  Peripheral generation and function of CD4+CD25+ regulatory T cells.

Authors:  L S Taams; A N Akbar
Journal:  Curr Top Microbiol Immunol       Date:  2005       Impact factor: 4.291

Review 4.  Thymic development and peripheral homeostasis of regulatory T cells.

Authors:  Adrian Liston; Alexander Y Rudensky
Journal:  Curr Opin Immunol       Date:  2007-02-15       Impact factor: 7.486

5.  Proteasome activity modulates chromatin modifications and RNA polymerase II phosphorylation to enhance glucocorticoid receptor-mediated transcription.

Authors:  H Karimi Kinyamu; Trevor K Archer
Journal:  Mol Cell Biol       Date:  2007-04-16       Impact factor: 4.272

6.  Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice.

Authors:  Mauro Provinciali; Francesca Papalini; Fiorenza Orlando; Sara Pierpaoli; Alessia Donnini; Paolo Morazzoni; Antonella Riva; Arianna Smorlesi
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

7.  Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer.

Authors:  Sebastian Hinz; Laia Pagerols-Raluy; Hans-Heinrich Oberg; Ole Ammerpohl; Sandra Grüssel; Bence Sipos; Robert Grützmann; Christian Pilarsky; Hendrik Ungefroren; Hans-Detlev Saeger; Günter Klöppel; Dieter Kabelitz; Holger Kalthoff
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

8.  Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia.

Authors:  Kensuke Kojima; Marina Konopleva; Teresa McQueen; Susan O'Brien; William Plunkett; Michael Andreeff
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

9.  FOXP3 controls regulatory T cell function through cooperation with NFAT.

Authors:  Yongqing Wu; Madhuri Borde; Vigo Heissmeyer; Markus Feuerer; Ariya D Lapan; James C Stroud; Darren L Bates; Liang Guo; Aidong Han; Steven F Ziegler; Diane Mathis; Christophe Benoist; Lin Chen; Anjana Rao
Journal:  Cell       Date:  2006-07-28       Impact factor: 41.582

10.  FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.

Authors:  Tao Zuo; Lizhong Wang; Carl Morrison; Xing Chang; Huiming Zhang; Weiquan Li; Yan Liu; Yin Wang; Xingluo Liu; Michael W Y Chan; Jin-Qing Liu; Richard Love; Chang-Gong Liu; Virginia Godfrey; Rulong Shen; Tim H-M Huang; Tianyu Yang; Bae Keun Park; Cun-Yu Wang; Pan Zheng; Yang Liu
Journal:  Cell       Date:  2007-06-14       Impact factor: 41.582

View more
  23 in total

Review 1.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

2.  IPEX Syndrome, FOXP3 and Cancer.

Authors:  Runhua Liu; Silin Li; Wei-Hsiung Yang; Lizhong Wang
Journal:  J Syndr       Date:  2013-06

Review 3.  Signalling through FOXP3 as an X-linked tumor suppressor.

Authors:  Hiroto Katoh; Pan Zheng; Yang Liu
Journal:  Int J Biochem Cell Biol       Date:  2010-08-01       Impact factor: 5.085

Review 4.  The dual role of the X-linked FoxP3 gene in human cancers.

Authors:  Margaret Redpath; Bin Xu; Leon C van Kempen; Alan Spatz
Journal:  Mol Oncol       Date:  2011-03-30       Impact factor: 6.603

5.  Foxp3 is a key downstream regulator of p53-mediated cellular senescence.

Authors:  J-E Kim; J-S Shin; J-H Moon; S-W Hong; D-J Jung; J H Kim; I-Y Hwang; Y J Shin; E-Y Gong; D H Lee; S-M Kim; E Y Lee; Y S Kim; D Kim; D Hur; T W Kim; K-P Kim; D-H Jin; W-J Lee
Journal:  Oncogene       Date:  2016-05-30       Impact factor: 9.867

6.  IL-23/IL-23R: potential mediator of intestinal tumor progression from adenomatous polyps to colorectal carcinoma.

Authors:  Feng Lan; Le Zhang; Junchao Wu; Jie Zhang; Sen Zhang; Kai Li; Yanyu Qi; Ping Lin
Journal:  Int J Colorectal Dis       Date:  2011-05-06       Impact factor: 2.571

Review 7.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

8.  FOXP3 regulates sensitivity of cancer cells to irradiation by transcriptional repression of BRCA1.

Authors:  Weiquan Li; Hiroto Katoh; Lizhong Wang; Xiaochun Yu; Zhanwen Du; Xiaoli Yan; Pan Zheng; Yang Liu
Journal:  Cancer Res       Date:  2013-01-14       Impact factor: 12.701

9.  Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53.

Authors:  Kyoung Wan Yoon; Sanguine Byun; Eunjeong Kwon; So-Young Hwang; Kiki Chu; Masatsugu Hiraki; Seung-Hee Jo; Astrid Weins; Samy Hakroush; Angelika Cebulla; David B Sykes; Anna Greka; Peter Mundel; David E Fisher; Anna Mandinova; Sam W Lee
Journal:  Science       Date:  2015-07-31       Impact factor: 47.728

10.  Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas.

Authors:  Sharmistha Pal; David Kozono; Xiaodong Yang; Wojciech Fendler; Whitney Fitts; Jing Ni; John A Alberta; Jean Zhao; Kevin X Liu; Jie Bian; Nathalene Truffaux; William A Weiss; Adam C Resnick; Pratiti Bandopadhayay; Keith L Ligon; Steven G DuBois; Sabine Mueller; Dipanjan Chowdhury; Daphne A Haas-Kogan
Journal:  Cancer Res       Date:  2018-05-14       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.